jetcityimage/iStock Editorial via Getty Images
Eli Lilly (NYSE:LLY) has launched its popular weight loss/diabetes therapy Mounjaro in India, beating its biggest rival, Novo Nordisk (NVO), in a market where obesity rates are fast rising, according to a statement from the U.S. drugmaker on Thursday.
The